当前位置: 首页 > 期刊 > 《中外医学研究》 > 2015年第10期
编号:13118222
第三代二氢吡啶钙拮抗剂乐卡地平治疗高血压病若干进展(3)
http://www.100md.com 2015年4月5日 《中外医学研究》 2015年第10期
     [8] Acanfora D,Trojano L,Gheorghiade M,et al.A randomized,double-blind comparison of 10 mg and 20 mg lercanidipine in patients with stable effort angina:Effects on myocardial ischemia and heart rate variability[J].Am J Ther,2002,18(5):444-453.

    [9]周连家.依那普利联合乐卡地平治疗高血压早期肾损害的临床疗效观察[J].中国医药指南,2014,12(11):250-251.

    [10] Viviani G L.Lercanidipine in type II diabetic patients with mild tomoderate arterail hypertension[J].J Cardiovasc Pharmacol,2002,40(1):133-139.

    [11] Mc Clellan K J.Jarvis B.Lercanidipine:a review of its use in hypertension[J].Drugs,2000,60(5):1123-1140.

    [12] Mancia G,Coca A,Girerd X,et al.Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial[J].Journal of Hypertension,2014,32(8):1700-1707.

    [13] Maldonado J,Pereira T,Tavares A.Efficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in Portugal[J].Drugs in R&D,2014,14(2):147-154.

    (收稿日期:2014-12-11) (编辑:金燕), 百拇医药(宋阿苗 彭崇俊 刘勇)
上一页1 2 3